Navigation Links
Nasal Cannula Treatment for Sleep Apnea Patients

Researchers at Johns Hopkins University have found that symptoms in patients with obstructive sleep apnea and hypopnea can be significantly reduced through treatment with nasal insufflation (TNI), using a nasal cannula to deliver warm, humidified air at a high flow rate.

Our findings provide evidence that TNI may offer a viable treatment alternative to patients with obstructive hypopneas and apneas, said lead researcher Hartmut Schneider, M.D., of Johns Hopkins Asthma and Allergy Center.

The research was reported in the second issue for July 2007 of the American Journal of Respiratory and Critical Care Medicine published by the American Thoracic Society.

The proof of concept study included 11 patients with mild to severe apnea-hypopnea disorders, who were selected to provide a balanced range of disease severity. Apnea was defined as complete cessation of airflow for more than 10 seconds. Hypopnea was defined as a greater than 30 percent reduction of airflow.

After baseline data were established for each patient while undergoing TNI at 0, 10 and 20L/minute, subjects were randomized to receive either no treatment or treatment with TNI at 20L/minute on separate nights. Researchers then measured airflow and superglottic pressure and monitored body position, sleep arousals and respiratory events.

At TNI of 10L/minute, some indications of disordered breathing showed improvement, but airflow limitations and snoring persisted. However, at TNI of 20L/minute, all patients showed a marked improvement. When TNI was administered, sleep and breathing patterns stabilized, said Dr. Schneider.

Furthermore, the results showed that even patients with more severe disorders gained significantly from TNI. Although we expected marked improvements in the apnea-plus-hypopnea index (AHI) primarily in patients with hypopneas rather than obstructive apneas, TNI lowered the AHI in all subjects, the researchers wrote.
'"/>




Page: 1 2 3

Related medicine news :

1. Nasal Spray Could Take Drugs Direct to Brain.
2. Nasal Spray Could Take Drugs Directly to Brain
3. Nasal Spray Beats Antihistamine
4. Nasal sprays used for other ailments!
5. Chronic Sinusitis May Be Related To Nasal Mucus
6. Stress – Buster : Hormonal Nasal Spra
7. Cluster Headaches Can Be Treated By Nasal Spray
8. Nasal Plastic Surgery Improves Airway Function
9. Compellis Pharmaceuticals Gets Patent for Obesity-Fighting Nasal Spray CP404
10. Patients Dissatisfied Following Closed Reduction Of Nasal Fractures
11. Surgeons Perform Nasal Reconstruction for War Veteran Using His Own Body Parts
Post Your Comments:
(Date:7/9/2008)..., Barcelona, Spain: New figures on assisted repro... has been an explosion in the use of ICSI (intracy...he 24th annual meeting of the European Society of ...lona heard today (Wednesday). Researchers believe ... too often. , In 2005 the most recent year for ...
(Date:7/8/2008)..., Alexandria, Va.A study conducted in Sweden foun...untry whose wives died from cancer four or five ye...hat their spouse,s cancer was incurable, or they h...life. Eighty-six percent of widowers believed next...ancer is incurable, including 71 percent of the me...
(Date:7/8/2008)... CHICAGO, July 8 /PRNewswire/ -- Last month th...e Improvements for Patient and Providers Act",(H.R...re payments to,physicians and other providers went...ent relationship in great jeopardy., , To view t...ewswire.com/mnr/osteopathic/33934/ , The American...
(Date:7/8/2008)... Heart Failure Study Validates Use of Pharos In...ing Platform to Reduce Healthcare Utilization and ...IELD, Ill., July 8 /PRNewswire/ -- Pharos Innovati...t generation clinical and financial,performance im...platform,announced today the results from the Iow...
Breaking Medicine News(10 mins):Health News:Researcher say that ICSI may be over-used in some countries 2Health News:Researcher say that ICSI may be over-used in some countries 3Health News:Study finds that significant proportion of men told wife's cancer was incurable late or not at all 2Health News:Audio: Medicare Cuts Threaten Access to Health Care for Seniors 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 3
...ise that constant stress can make people sick, and...study focused on 119 men and women who were taking...caregivers was compared with that of 106 people of...e stress of constant care giving. Blood tests show...
...investigators more than 10 million children worldw...nd many of them preventable with existing medical ...these nations has dropped over the past half centu...f of the deaths in children under 5 take place in ...
...le who are bitten by animals poses little problem ... another human? That’s the question researchers se...onth’s Otolaryngology -- Head and Neck Surgery. Th...ords in Galveston, Texas, identified several key a...
... that early detection is important for preventing ...be as easy as mirrors with no tricks, just light.J...e’s lucky doctors were able to treat him despite a...ound a primary, which is what you call the skin ca...
Other Medicine News:
(Date:7/8/2008)...RNewswire/ -- Avir Green Hills Biotechnology,start...cine deltaFLU,against pandemic influenza. This nov...n the deletion of the NS1 gene has shown superior,...e biotech company sets,yet another milestone in th...m of Phase I Study, The randomized, double-blind ...
(Date:7/8/2008).../- After meeting on July 1st and,2nd ...betes drugs should,undergo trials to rule out card...f US endocrinologists agree with this recommendati...diovascular and metabolic primary market,research ...obal Life,Sciences Industry., On July 3rd AlphaDe...
(Date:7/8/2008)...eets primary endpoints in ENGAGE Trial, KENILWORT...-Plough,Corp., (NYSE: SGP ) announced today that ...follicle stimulant (SFS) met its primary endpoints...presented during a,Schering-Plough-sponsored sympo...ciety of Human Reproduction and Embryology (ESHRE)...
(Date:7/7/2008)...proves Cognition and is Well Tolerated in ...ndings Warrant Further Development in Huntington,s...Today at 5:00 p.m. EDT -, SAN FRANCISCO, July 7 /... MDVN ) today announced top-line results of a Pha...imebon(TM) significantly improved cognitive,functi...
Breaking Medicine Technology:Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU 2Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU 3AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panel's Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications. 2Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant 2Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant 3Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 2Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 3Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 4Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 5UCR plant cell biologist to study how plant stem cells maintain and change their identity 297 1UCR plant cell biologist to study how plant stem cells maintain and change their identity 297 2Prime Therapeutics Receives TIPPS Certification 729 1Prime Therapeutics Receives TIPPS Certification 729 2Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences 727 1Standard Management Announces OTCBB Listing 725 1Standard Management Announces OTCBB Listing 725 2
...monstrate Significant Survival Benefit in,Liver Ca...ll/ -- Bayer,HealthCare Pharmaceuticals Inc. and O...avar(R) (sorafenib) tablets significantly,extended...carcinoma,(HCC), or primary liver cancer versus th...). Results were presented at the 43rd,annual meeti...
...NESS WIRE)--Jun 4, 2007 - GenVec, Inc.,(Nasdaq: GN...y and,efficacy data from the clinical development ...nted in a poster session on,gastrointestinal cance...linical Oncology in Chicago, IL by Dr. Mitchell Po...sion of the posters then,concluded the Saturday mo...
Other Medicine Technology:Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 2GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 3GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 4
...igation system for ENT, cranial and spine procedur...y, critical zones visible during tracking. Image f...n freezes image, snapshot can be taken of frozen i...the microscope, low profile receiver attachment. A...
The spinal system neon is a modular system for posterior stabilization. Its application range extends from occipitocervical via cervical to cervicothoracic applications. In the case of children, it c
Bacon Cranial Rongeur
Cushing Pituitary Rongeur
Medicine Products: